Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

205
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
205
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

895
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
895
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

121
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
121
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

150
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
150
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of Prone Positioning in Mechanically Ventilated COVID-19 Patients.

Respiratory care·2025
Same author

Intrathoracic Migration of a Breast Implant.

The New England journal of medicine·2024
Same author

A Masking Effect: A Case of Initial Presentation of Ulcerative Colitis After Discontinuing Growth Hormone Therapy.

Crohn's & colitis 360·2023
Same author

Evaluation of the Diagnostic Accuracy and Clinical Utility of Fungal Profile Plus Polymerase Chain Reaction Assay in Pulmonary Infections.

Open forum infectious diseases·2022
Same author

An Uncommon Cause of Bronchial Obstruction.

Annals of the American Thoracic Society·2020
Same author

Ruxolitinib is an effective steroid sparing agent in bronchiolitis obliterans due to chronic graft-versus-host-disease.

Bone marrow transplantation·2019

Related Experiment Video

Updated: May 29, 2025

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

5.0K

Acute Lung Injury in Immunocompromised Patients.

Brogan Barry1, Dane Stewart1, Kyle R Brownback2

  • 1Department of Internal Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, MailStop 3007, Kansas City, KS 66160, USA.

Clinics in Chest Medicine
|January 31, 2025
PubMed
Summary

Acute lung injury (ALI) is a growing concern in immunocompromised patients. Early recognition of infection as a common cause is crucial for timely diagnosis and management.

Keywords:
ARDSHypoxemiaImmunocompromisedLungVentilation

More Related Videos

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation
11:07

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Published on: July 6, 2019

24.8K
Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
08:27

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury

Published on: May 21, 2018

10.8K

Related Experiment Videos

Last Updated: May 29, 2025

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

5.0K
Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation
11:07

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Published on: July 6, 2019

24.8K
Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
08:27

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury

Published on: May 21, 2018

10.8K

Area of Science:

  • Pulmonology
  • Immunology
  • Critical Care Medicine

Background:

  • Acute lung injury (ALI) is a severe complication in immunocompromised individuals.
  • The incidence of ALI in this population is increasing due to advances in medical care allowing longer survival.
  • Immunocompromised patients represent a vulnerable group susceptible to severe respiratory distress.

Purpose of the Study:

  • To highlight the increasing incidence and significance of acute lung injury in immunocompromised patients.
  • To emphasize the importance of recognizing potential causes, particularly infection, for earlier diagnosis.
  • To outline current management strategies for acute lung injury in this patient cohort.

Main Methods:

  • This abstract is based on a review of current medical literature and clinical understanding.
  • It synthesizes information regarding the causes, diagnosis, and management of ALI in immunocompromised hosts.
  • No specific experimental methods were employed; it is a conceptual overview.

Main Results:

  • Infection is identified as a frequent and critical cause of acute lung injury in immunocompromised patients.
  • Awareness of potential etiologies facilitates earlier detection and diagnosis of ALI.
  • The diagnostic process for ALI in this group must include infectious causes.

Conclusions:

  • Acute lung injury poses a significant threat to immunocompromised patients, with rising incidence.
  • Prompt identification of infectious agents is paramount for effective management of ALI.
  • Supportive care, including mechanical ventilation and potential pharmacological interventions, forms the cornerstone of ALI treatment.